Results
13
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
13 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ROG | CHF 261.60 | -1.6% | 10.4% | CHF 210.3b | CHF 303.88 | PE19.6x | E11.1% | 3.7% | ||
NOVN | CHF 92.73 | -0.3% | 11.4% | CHF 185.4b | CHF 104.18 | PE17.7x | E7.0% | 3.4% | ||
GALD | CHF 85.66 | 4.9% | n/a | CHF 20.3b | CHF 89.49 | PS5.3x | E44.4% | n/a | ||
SDZ | CHF 39.77 | -0.2% | 53.7% | CHF 17.1b | CHF 41.71 | PS1.9x | E34.3% | 1.1% | ||
SFZN | CHF 1,132.00 | 1.1% | 46.4% | CHF 4.9b | CHF 1,187.67 | PE37.7x | E13.6% | 0.3% | ||
TECN | CHF 214.40 | -2.5% | -26.6% | CHF 2.7b | CHF 295.29 | PE27.1x | E15.3% | 1.4% | ||
COPN | CHF 64.70 | -0.8% | 70.7% | CHF 1.0b | CHF 97.30 | PE15.9x | E17.2% | 2.9% | ||
PPGN | CHF 30.40 | -3.9% | 50.8% | CHF 1.0b | CHF 36.25 | PS3.3x | E64.2% | 0% | ||
BSLN | CHF 40.70 | -4.2% | 14.0% | CHF 493.3m | CHF 77.25 | PS3.3x | E26.9% | 0% | ||
XLS | CHF 28.00 | 20.2% | -27.3% | CHF 160.8m | n/a | PE7.6x | n/a | n/a | ||
SANN | CHF 8.48 | -2.0% | -11.5% | CHF 102.7m | CHF 32.00 | PE1.6x | E35.4% | n/a | ||
ADXN New | CHF 0.065 | -23.8% | 40.9% | CHF 6.4m | CHF 0.16 | PS7.4x | E33.3% | n/a | ||
OBSN | CHF 0.0012 | 0% | -98.2% | CHF 140.6k | n/a | PE0.02x | n/a | n/a |